BL-8040 Speeds Collection of Stem Cells for Transplant in Myeloma Patients, Phase 3 Data Suggest
Adding BioLineRx‘s BL-8040 to standard treatment greatly…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
Surface Oncology’s SRF231 Granted Orphan Drug Status for Treatment of Multiple Myeloma
SRF231, an experimental anti-CD47 immunotherapy candidate developed by…
Investigational Immunotherapy SRF231 Granted FDA Orphan Drug Status for Multiple Myeloma
The U.S. Food and Drug Administration has granted orphan…
CHMP Recommends Darzalex Combo Therapy for Certain Newly Diagnosed Multiple Myeloma Patients
Expanded use of Darzalex (daratumumab) in combination with standard therapy…
Machine-learning Algorithm Predicts Responses to Myeloma Treatments
Inserting data from genetically similar patients into a machine-learning…
Urine Tests May Be Better Than Serum for Multiple Myeloma Screening, Study Suggests
Urine tests may be better than serum…
